Log in
RegisterPaliperidone palmitate study design [Design Issues]
Thanks alot Detlew for your reply
Another question does the side of the body mean right or left side of the body will contribute to variability between test to reference? or the model should include another factor for grouping based on right / left side of the body if the subjects were divided into left side injection and right side ? according to spc : alternate injection sites between sides of the body ?
Thanks in advance
Another question does the side of the body mean right or left side of the body will contribute to variability between test to reference? or the model should include another factor for grouping based on right / left side of the body if the subjects were divided into left side injection and right side ? according to spc : alternate injection sites between sides of the body ?
Thanks in advance
Complete thread:
- Paliperidone palmitate IM model effects M.tareq 2017-06-27 23:46
![[Mix]](https://static.bebac.at/img/mix.png "open in Mix view")
- Paliperidone palmitate study design d_labes 2017-06-29 11:05
- Paliperidone palmitate study designM.tareq 2017-06-29 12:47
- Paliperidone palmitate study design d_labes 2017-06-30 19:28
- Paliperidone palmitate study design M.tareq 2017-08-07 21:48
- Paliperidone palmitate study design d_labes 2017-06-30 19:28
- Paliperidone palmitate study designM.tareq 2017-06-29 12:47
- Paliperidone palmitate study design d_labes 2017-06-29 11:05
Ing. Helmut Schütz